Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, non-small cell lung carcinoma, prostate cancer, prostate disorder, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 12026-01-12NCT07181473

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Phrontline Biopharma2

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Florida Cancer Specialists & Research InstituteOrlandoUnited States1
Henan Cancer HospitalZhengzhouChina98
Oncology ConsultantsHoustonUnited States22
Sarah Cannon Research Institute (SCRI)NashvilleUnited States7
Shanghai East HospitalShanghaiChina33
Sir Run Run Shaw HospitalHangzhouChina7
Union Hospital of Tongji Medical CollegeWuhanChina1